» Articles » PMID: 26702314

Effects of a High-fat Diet on the Electrical Properties of Porcine Atria

Abstract

Background: Because obesity is an important risk factor for atrial fibrillation (AF), we conducted an animal study to examine the effect of a high-fat diet (HFD) on atrial properties and AF inducibility.

Methods: Ten 8-week-old pigs (weight, 18-23 kg) were divided into two groups. For 18 weeks, five pigs were fed a HFD (HFD group) and five were fed a normal diet (control group). Maps of atrial activation and voltages during sinus rhythm were created for all pigs using the EnSite NavX system. Effective refractory period (ERP) and AF inducibility were also determined. When AF was induced, complex fractionated atrial electrogram (CFAE) mapping was performed. At 18 weeks, hearts were removed for comparing the results of histological analysis between the two groups. Body weight, lipid levels, hemodynamics, cardiac structures, and electrophysiological properties were also compared.

Results: Total cholesterol levels were significantly higher (347 [191-434] vs. 81 [67-88] mg/dL, P=0.0088), and left atrium pressure was higher (34.5 [25.6-39.5] vs. 24.5 [21.3-27.8] mmHg, P=0.0833) in the HFD group than in the control group, although body weight only increased marginally (89 [78-101] vs. 70 [66-91] kg, P=0.3472). ERPs of the pulmonary vein (PV) were shorter (P<0.05) and AF lasted longer in the HFD group than in the control group (80 [45-1350] vs. 22 [3-30] s, P=0.0212). Neither CFAE site distribution nor histopathological characteristics differed between the two groups.

Conclusions: The shorter ERPs for the PV observed in response to the HFD increased vulnerability to AF, and these electrophysiological characteristics may underlie obesity-related AF.

Citing Articles

Associated Factors and Mortality of Arrhythmia in Emergency Department: A Narrative Review.

Gaur U, Gadkari C, Pundkar A Cureus. 2024; 16(9):e68645.

PMID: 39371719 PMC: 11451514. DOI: 10.7759/cureus.68645.


Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.

Bode D, Pronto J, Schiattarella G, Voigt N Nat Rev Cardiol. 2024; 21(10):682-700.

PMID: 38816507 DOI: 10.1038/s41569-024-01038-6.


Impact of Obesity on Atrial Electrophysiological Substrate.

Schram Serban C, de Groot N J Cardiovasc Dev Dis. 2023; 10(8).

PMID: 37623355 PMC: 10455641. DOI: 10.3390/jcdd10080342.


Obesity-Related Atrial Fibrillation: Cardiac Manifestation of a Systemic Disease.

Limpitikul W, Das S J Cardiovasc Dev Dis. 2023; 10(8).

PMID: 37623336 PMC: 10455513. DOI: 10.3390/jcdd10080323.


Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance.

Gawalko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D Cardiovasc Res. 2022; 119(3):614-630.

PMID: 35689487 PMC: 10409902. DOI: 10.1093/cvr/cvac093.


References
1.
Teijeira-Fernandez E, Eiras S, Shamagian L, Somoza A, Delgado C, Gonzalez-Juanatey J . Lower epicardial adipose tissue adiponectin in patients with metabolic syndrome. Cytokine. 2011; 54(2):185-90. DOI: 10.1016/j.cyto.2011.01.016. View

2.
Ford E, Mokdad A, Giles W, Brown D . The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003; 52(9):2346-52. DOI: 10.2337/diabetes.52.9.2346. View

3.
Patterson E, Po S, Scherlag B, Lazzara R . Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005; 2(6):624-31. DOI: 10.1016/j.hrthm.2005.02.012. View

4.
Bode F, KATCHMAN A, Woosley R, Franz M . Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation. 2000; 101(18):2200-5. DOI: 10.1161/01.cir.101.18.2200. View

5.
Lopez F, Agarwal S, MacLehose R, Soliman E, Sharrett A, Huxley R . Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circ Arrhythm Electrophysiol. 2012; 5(1):155-62. PMC: 3290134. DOI: 10.1161/CIRCEP.111.966804. View